Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register

Overview of attention for article published in Arthritis Research & Therapy, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 9 X users
facebook: 1 Facebook page

Readers on

mendeley: 37 Mendeley

Summary News Blogs X Facebook

So far, Altmetric has seen 2 news stories from 2 outlets.

Age at biologic DMARD initiation impacts adverse event risk

medwireNews, 30 Jun 2020

medwireNews: The likelihood of experiencing an adverse event (AE) after initiating treatment with a first biologic DMARD…

Adverse Events With Rheum Biologics Rise With Age

MedPage Today, 18 Jun 2020

Rheumatology > General Rheumatology Risks also increased for women and those with concomitant treatments and comorbidities…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.